Revenue
$48.5B
Gross Margin
+68.7%
Operating Margin
+25.7%
Net Margin
+15.0%
Income statement waterfall for Bristol-Myers Squibb (BMY) — TTM through Q1 2026
Net income: $7.28B
Margin breakdown for Bristol-Myers Squibb (BMY) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $48.5B | $48.5B |
| Cost of Revenue | -$15.2B | $33.3B |
| Gross Profit | $33.3B | $33.3B |
| Operating Expenses | -$20.9B | $12.4B |
| Operating Income | $12.4B | $12.4B |
| Other Income / Expense | -$2.85B | $9.6B |
| Pre-tax Income | $9.6B | $9.6B |
| Income Tax | -$2.32B | $7.27B |
| Net Income | $7.28B | $7.28B |
- Revenue$48.5B
- Cost of Revenue-$15.2B
- Gross Profit$33.3B
- Operating Expenses-$20.9B
- Operating Income$12.4B
- Other Income / Expense-$2.85B
- Pre-tax Income$9.6B
- Income Tax-$2.32B
- Net Income$7.28B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.08% TTM
- Dividend Profile4.13% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.